SelectQuote Receives NYSE Delisting Notice for Sub-$1.00 Stock Price

summarizeSummary

SelectQuote, Inc. received a notice from the NYSE regarding non-compliance with the minimum $1.00 average closing price rule, initiating a six-month cure period to avoid delisting.

check_boxKey Events

• NYSE Delisting Notice Received

  On March 19, 2026, SelectQuote, Inc. received a notice from the New York Stock Exchange (NYSE) regarding non-compliance with its continued listing standards.

• Non-Compliance with $1.00 Minimum Price

  The notice indicates that the company's common stock had an average closing price of less than $1.00 per share over a consecutive 30 trading-day period, violating Section 802.01C of the NYSE Listed Company Manual.

• Six-Month Cure Period Initiated

  The company has a six-month period to regain compliance. This requires the stock to have a closing price of at least $1.00 and an average closing price of at least $1.00 over a 30 trading-day period by the end of any calendar month during this period.

• Company Plans to Regain Compliance

  SelectQuote intends to notify the NYSE of its plan to cure the deficiency and will monitor its stock price, considering available alternatives, including actions that may require stockholder approval, to maintain its listing.

auto_awesomeAnalysis

SelectQuote, Inc. has received a formal notice from the New York Stock Exchange (NYSE) indicating non-compliance with the minimum $1.00 average closing price requirement. This is a critical event as failure to regain compliance within the six-month cure period could lead to the company's common stock being delisted from the NYSE, potentially moving to an over-the-counter market. Such a move typically results in reduced liquidity and investor interest, negatively impacting shareholder value. The company's ability to implement a successful strategy, possibly including a reverse stock split, to boost its share price above the $1.00 threshold will be a key focus for investors over the next six months.